CARCINOGENS AND CHROMATIN STRUCTURE AND FUNCTION
致癌物和染色质结构与功能
基本信息
- 批准号:6375614
- 负责人:
- 金额:$ 24.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-06-01 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:ADP ribosylation DNA directed DNA polymerase DNA repair DNA replication adenosine diphosphate apoptosis carcinogen testing chemical carcinogen chemical carcinogenesis chemical structure function chromatin enzyme activity genetic recombination genetically modified animals laboratory mouse mutagen testing nucleic acid structure p53 gene /protein pentosyltransferase pulsed field gel electrophoresis transcription factor
项目摘要
Poly(ADP-ribose) polymerase (PARP) is activated by binding to DNA
strand breaks and contributes to various nuclear processes involving DNA strand
breaks. This amended proposal aims to characterize the precise roles of PARP in
DNA replication-repair and in apoptosis. It is based on the overall hypothesis
that the covalent attachment of long, negatively charged chains of
poly(ADP-ribose) (PAR) renders target DNA-binding proteins "DNA-phobic" and
that removal of PAR would then restore the affinity of these proteins for
binding sites on DNA.
Specific Aim 1A focuses on the role of PARP as a component of the multiprotein
replication complex (MRC), or "synthesome", which comprises about 40 proteins
and is able to replicate, faithfully, SV40 DNA. MRCs derived from several
cancer cell are error-prone. Several MRC components undergo
poly(ADP-ribosyl)ation [p(ADP-R)n]; the use of cells from PARP knockout mice
will be used to determine the function(s) of p(ADP-R)n on MRC proteins during
DNA replication. To this end, the applicant will initially focus on one major
facet--whether the MRC, purified from PARP knockout cells versus controls,
exhibits a defect similar to cancer cells, that of error-prone replication.
Specific Aim 1B focuses on E2F-1, which is normally induced during S phase of
the cell cycle, but is not so expressed in cells from PARP knockout mice. The
mechanism by which PARP regulates the promoter activity of this gene will
therefore be investigated. In addition, the applicant will examine the direct
interaction of PARP with the E2F-1 promoter directly, or in combination with
other signal proteins that act with E2F-1, as well as direct or indirect
effects of p(ADP-R)n on expression of E2F-1.
Specific Aim 2 is focused on the role of the early and transient p(ADP-R)n of
nuclear proteins, described during the last grant period, which occurs early
during apoptosis and is required for many of the subsequent changes
characteristic of programmed cell death. The temporal and spatial relations of
this transient p(ADP-R)n to changes in the structure of chromatin and the
nuclear matrix will be examined systematically and compared, in part, by using
PARP+/+ cells vs. PARP-/- cells to detect the function of p(ADP-R)n at this
early critical point of apoptosis.
The focus of Specific Aim 3 is the transcription factor and tumor suppressor
p53, one of the major targets of p(ADP-R)n during apoptosis. The applicant
identified p53 to be p(ADP-R)n briefly during the early burst of PAR in
apoptosis. The subsequent cleavage of PAR from p53 coincides temporally with
the activation of its target gene BAX. The mechanistic relation between this
reversible modification of p53 and its transactivation activity and function
will be determined in vitro and in the context of the whole cell by the use of
gel shift assays and the activity of other p53 responsive genes.
通过与DNA结合激活聚(ADP-核糖)聚合酶(PARP)
链断裂并有助于涉及DNA链的各种核过程
休息。这项修订的建议旨在表征PARP的精确作用
DNA复制修复和凋亡。它基于整体假设
长长,负电荷的链的共价附件
聚(ADP-核糖)(PAR)渲染目标DNA结合蛋白“ DNA-恐惧症”和
然后去除PAR将恢复这些蛋白质的亲和力
DNA上的结合位点。
特定的目标1A专注于PARP作为多蛋白的组成部分的作用
复制复合物(MRC)或“合成”,该复制复合物包括约40种蛋白
并能够忠实地复制SV40 DNA。 MRC来自几个
癌细胞容易出错。几个MRC组件发生
聚(ADP-核糖基)[P(ADP-R)N];使用PARP基因敲除小鼠的细胞
将用于确定在MRC蛋白上的P(ADP-R)N的功能
DNA复制。为此,申请人最初将专注于一个主要
方面 - MRC是否从PARP基因敲除单元与对照组中纯化,
表现出类似于癌细胞的缺陷,即易于错误的复制。
特定的目标1B专注于E2F-1,通常在S期诱导的E2F-1
细胞周期,但在PARP基因敲除小鼠的细胞中不太表达。这
PARP调节该基因启动子活性的机制将
因此被调查。此外,申请人将检查直接
PARP与E2F-1启动子的相互作用,或与E2F-1启动子的相互作用,或与
与E2F-1一起起作用的其他信号蛋白以及直接或间接的
P(ADP-R)N对E2F-1表达的影响。
特定目标2的重点是早期和瞬态P(ADP-R)N的作用
核蛋白,在上一个赠款期间描述,早期发生
在凋亡期间,随后的许多变化是必需的
程序性细胞死亡的特征。的时间和空间关系
该瞬态P(ADP-R)N与染色质结构的变化和
将系统地检查核矩阵,并通过使用
PARP+/+细胞与PARP - / - 细胞在此检测P(ADP-R)N的功能
凋亡的早期关键点。
特定目标3的重点是转录因子和肿瘤抑制剂
p53,凋亡过程中P(ADP-R)N的主要靶标之一。申请人
在PAR早期爆发期间,将p53识别为p(adp-r)n
凋亡。随后从p53的PAR裂解与
其靶基因BAX的激活。这之间的机械关系
p53的可逆修改及其反式激活活性和功能
将通过使用
凝胶转移测定和其他p53反应性基因的活性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK E SMULSON其他文献
MARK E SMULSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK E SMULSON', 18)}}的其他基金
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
- 批准号:
2086109 - 财政年份:1979
- 资助金额:
$ 24.2万 - 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
- 批准号:
3163723 - 财政年份:1979
- 资助金额:
$ 24.2万 - 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
- 批准号:
3163724 - 财政年份:1979
- 资助金额:
$ 24.2万 - 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
- 批准号:
3163721 - 财政年份:1979
- 资助金额:
$ 24.2万 - 项目类别:
HISTONE ADP-RIBOSYLATION AND HELA CELL REPLICATION
组蛋白 ADP-核糖基化和 HELA 细胞复制
- 批准号:
3163718 - 财政年份:1979
- 资助金额:
$ 24.2万 - 项目类别:
相似国自然基金
金属离子调控Y家族聚合酶Dpo4合成能力和保真性的机制
- 批准号:21576117
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Understanding the impact of DNA ADP-ribosylation on telomere function in cancer cells
了解 DNA ADP-核糖基化对癌细胞端粒功能的影响
- 批准号:
10751121 - 财政年份:2023
- 资助金额:
$ 24.2万 - 项目类别:
Regulation and function of site-specific protein poly-ADP-ribosylation
位点特异性蛋白质聚 ADP 核糖基化的调控和功能
- 批准号:
10668492 - 财政年份:2022
- 资助金额:
$ 24.2万 - 项目类别:
FLAGGING OF DNA DAMAGE SITES BY RNA POLYMERASE II
通过 RNA 聚合酶 II 标记 DNA 损伤位点
- 批准号:
2458310 - 财政年份:1996
- 资助金额:
$ 24.2万 - 项目类别:
FLAGGING OF DNA DAMAGE SITES BY RNA POLYMERASE II
通过 RNA 聚合酶 II 标记 DNA 损伤位点
- 批准号:
2748917 - 财政年份:1996
- 资助金额:
$ 24.2万 - 项目类别:
PROPERTIES OF A NEW HUMAN DNA REPAIR COMPLEX
新型人类 DNA 修复复合物的特性
- 批准号:
2187991 - 财政年份:1993
- 资助金额:
$ 24.2万 - 项目类别: